 CAMBRIDGE, Mass.--BUSINESS WIRE--- ALVR celltherapy--AlloVir, Inc. Nasdaq: ALVR, a late clinical-stage cell therapy company, will present a corporate overview at the 39th Annual J.P. Morgan Healthcare Conference on January 11, 2021 at 9:10 a.m. ET. An audio-only webcast of the presentation will be available on January 11th on the Investors Press section of the AlloVir website at An archived replay of the presentation will be available for approximately 30 days following the presen 